Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MILIS: Propranolol and Hyaluronidase in Acute MI
NCT00000493Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1977
- Modality
- Therapeutic Enzymes, Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of propranolol and hyaluronidase in myocardial infarction (MI) (5 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Ultimate size of acute myocardial infarction. Started Sep 1977; status: completed.
02
Drugs
propranololhyaluronidase
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00000493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000493.